NCBiotech News

Dignify Therapeutics, a pharmaceutical and medical device development company in Research Triangle Park, has received a major federal award to advance its main drug candidate for treating bladder and bowel dysfunction.

The award will provide over $4 million to support Dignify’s pre-clinical and clinical development of DTI-117, a novel neuropeptide that can induce on-demand voiding. 

NCBiotech portfolio company APIE Therapeutics is raising a Series A round of funding with the support of a new board member, former BIO president and CEO Jim Greenwood.

Advanced Animal Diagnostics, a Morrisville diagnostics and data systems company, has created the subsidiary Ad Astra Diagnostics to focus on human diagnostics.

Thermo Fisher Scientific’s PPD clinical research business, based in Wilmington, was awarded a five-year contract to provide regulatory affairs support and related services for the NIH’s new Blueprint MedTech program, which supports development of translational neurological devices.

Fintech company Lendio has ranked North Carolina fifth in its 2023 list of best states for small business.

Raleigh-based chemical and biomolecular diagnostic company Animal Cancer Dx is changing its name to Oncotect, and opening the door to applying its platform to human disease in the process. 

Emmes, a rapidly expanding contract research organization based in Rockville, Md., has opened a North Carolina office in Wilmington staffed with a dozen employees, including two top executives

Durham-based Clinetic, spun out of Duke University in 2017, says it has hit a milestone by signing its 10th academic health system agreement that links hospital data with clinical studies.

Duke University’s Fuqua School of Business will address “Innovation and Disruption: Technology’s Role in Transforming Health Care.” at its annual MBA health care conference on Wednesday, March 22, on West Campus.

Iowa-based Mazen Animal Health, which has an R&D facility in RTP, has received a patent for its technology to produce orally delivered animal vaccines in plants such as corn.

NCBiotech awarded 19 grants and loans totaling more than $2.3 million to universities, bioscience companies and nonprofit organizations in the second quarter of its fiscal year.

Surry County seventh graders got to be forensic scientists in a BioNetwork outreach program hosted by the local community college.

Morrisville life sciences professional services organization Kymanox has acquired the European company anteris in a move that expands Kymanox’s reach in the EU.

After receiving a grant from NCBiotech, Appalachian State University assistant professor Michael Reddish, Ph.D., landed a campus record $1.6 million in NIH funding.